Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
Parallel applications based on TROPION-Lung01 and TROPION-Breast01 phase 3 trial results demonstrating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan significantly improved...

West Indies Capitalise on Dhaka Dominance as Bangladesh Fight for Survival in Sylhet
Brown’s late block lifts 76ers past Pistons as LeBron makes 16,000 mark
Chinese tape maker Crown New Materials surges 787% in Shenzhen debut, creating paper billionaires
Ekadashi kab hai in 2026: Rama on Nov 5, Devutthana on Nov 20, Papankusha on Oct 22
Navy Court-Martials Captain, Lieutenant Commander Over INS Brahmaputra Capsizing 





























